ONCOTHYREON INC.
10Patents
8Active
10Granted
45Portfolio score
Filing activity: Mar 27, 2002 → Sep 17, 2014 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7820627B2 | Lipid A and other carbohydrate ligand analogs | Chemistry; Metallurgy | 23 | Expired |
| US7741297B2 | Immunostimulatory, covalently lipidated oligonucleotides | Human Necessities | 12 | Active |
| US8889616B2 | MUC1 based glycolipopeptide vaccine with adjuvant | Human Necessities | 11 | Active |
| US8097593B1 | Lipid A and other carbohydrate ligand analogs | Chemistry; Metallurgy | 6 | Active |
| US8198400B2 | Vaccine for modulating between T1 and T2 immune responses | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8871250B2 | Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine | Physics | 1 | Active |
| US8552145B2 | Vaccine for modulating between T1 and T2 immune responses | Emerging Cross-Sectional Technologies | 1 | Active |
| US9173929B2 | Mucinous glycoprotein (MUC-1) vaccine | Human Necessities | 0 | Active |
| US8329639B2 | MUC1 based glycolipopeptide vaccine with adjuvant | Human Necessities | 0 | Active |
| US9119784B2 | Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.